While your baby may not have made his big entrance yet, it's important to understand the recommended vaccines and schedule now. That's because your child’s immunizations will play a major role during ...

Arexvy is currently approved for use in all individuals aged 60 and older, as well as for high-risk individuals aged 50-59.

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...

The CDC's Vaccine Recommendations Draw Scrutiny Amid Controversial Changes** In a move that raises eyebrows, the Centers for Disease Control and Prevention (CDC) h ...

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...

Failure to recognize and resolve problems in an honest and evidence-based manner is the root cause of increasing vaccine ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...